“…ES products derived from different developmental stages of T. spiralis may act different immunomodulatory effects ( Yang et al., 2014 ; Jin et al., 2019a ). Many experimental studies have shown that infection with T. spiralis or exposure to ES products of T. spiralis induced a strong Th2/Treg response correlated with the stimulation of anti-inflammatory cytokines (IL-4, IL-5, and IL-13) and regulatory cytokines (IL-10, TGF-β), as well as the inhibition of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) ( Han et al., 2019 ; Sun et al., 2019b ; Ding et al., 2020 ). T. spiralis ES has been successfully used for the treatment of inflammatory bowel diseases ( Yang et al., 2014 ; Jin et al., 2019a ; Wang Z. et al., 2020 ), allergic asthma ( Sun et al., 2019a ) and sepsis ( Du et al., 2014 ) in mouse models.…”